• +1-646-491-9876
    • +91-20-67278686

    Search

    Global Hospital-Acquired Infection Control Market 2017-2021

    Global Hospital-Acquired Infection Control Market 2017-2021

    • Report Code ID: RW0001866731
    • Category Life Sciences
    • No. of Pages 94
    • Publication Month Jul-17
    • Publisher Name Infiniti Research
    About Hospital-Acquired Infection Control

    HAIs, which are also called nosocomial infections, refer to a collection of conditions that a patient may develop when being treated in hospitals or other healthcare facilities. Modern healthcare settings use multiple devices to treat patients. These can be breeding grounds for microorganisms, which can have adverse effects on patient health. HAIs have caused a significant cost burden on patients and healthcare facilities.

    Publisher's analysts forecast the global hospital-acquired infection control market to grow at a CAGR of 4.81% during the period 2017-2021.

    Covered in this report
    The report covers the present scenario and the growth prospects of the global hospital-acquired infection control market for 2017-2021. To calculate the market size, the report considers the revenue generated from the sales of HAI products.

    The market is divided into the following segments based on geography:
    -Americas
    -APAC
    -EMEA

    Publisher's report, Global Hospital-Acquired Infection Control Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

    Key vendors
    -AstraZeneca
    -GlaxoSmithKline
    -Merck
    -Pfizer

    Other prominent vendors
    -3M
    -Abbott Laboratories
    -AbbVie
    -Advanced Sterilization Products
    -Alere
    -Bayer
    -BD
    -bioMérieux
    -Cepheid
    -Getinge Group
    -Hoffmann La-Roche
    -Synergy Health
    -Xenex

    Market driver
    -Increasing innovative measures to prevent HAIs
    -For a full, detailed list, view our report

    Market challenge
    -Emergence of antibiotic resistance
    -For a full, detailed list, view our report

    Market trend
    -Emergence of innovative techniques to remove biofilms
    -For a full, detailed list, view our report

    Key questions answered in this report
    -What will the market size be in 2021 and what will the growth rate be?
    -What are the key market trends?
    -What is driving this market?
    -What are the challenges to market growth?
    -Who are the key vendors in this market space?
    -What are the market opportunities and threats faced by the key vendors?
    -What are the strengths and weaknesses of the key vendors?

    You can request one free hour of our analyst's time when you purchase this market report. Details are provided within the report.
    PART 01: Executive summary
    PART 02: Scope of the report
    PART 03: Research Methodology
    PART 04: Introduction
    -Overview
    PART 05: Market landscape
    -Overview
    -Market size and forecast
    -Five forces analysis
    PART 06: Segmentation by infection type
    -Overview
    -CAUTIs
    -SSIs
    -CLABSIs
    -Respiratory infections
    PART 07: Segmentation by end-user
    -Overview
    -Hospitals and ICUs
    -Outpatient care centers
    -LTCFs
    -Others
    PART 08: Segmentation by geography
    -Overview
    -Americas
    -EMEA
    -APAC
    PART 09: Decision framework
    PART 10: Drivers and challenges
    -Market drivers
    -Market challenges
    PART 11: Market trends
    -Emergence of innovative techniques to remove biofilms
    -Decrease in regulatory approvals of antibiotics
    -Focus on early diagnosis and preventive medicine
    -Cost burden of HAIs on patients and hospitals
    PART 12: Vendor landscape
    -Competitive scenario
    PART 13: Key vendor analysis
    -AstraZeneca
    -GlaxoSmithKline
    -Merck
    -Pfizer
    -Other prominent vendors
    PART 14: Appendix
    -List of abbreviations
    AstraZeneca
    GlaxoSmithKline
    Merck
    Pfizer
    3M
    Abbott Laboratories
    AbbVie
    Advanced Sterilization Products
    Alere
    Bayer
    BD
    bioMérieux
    Cepheid
    Getinge Group
    Hoffmann La-Roche
    Synergy Health
    and Xenex.

    Request for Sample

    Report Url https://www.reportsweb.com//global-hospital-acquired-infection-control-market-2017-2021&type=sample
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire before Buying

    Report Url https://www.reportsweb.com//global-hospital-acquired-infection-control-market-2017-2021&type=buying
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments
     

    Inquire for Discount

    Report Url https://www.reportsweb.com//global-hospital-acquired-infection-control-market-2017-2021&type=discount
    Report Name
    First Name
    Last Name
    Email
    Phone
    Company
    Job Title
    Country
    Publisher
    Report Code
    Comments